Our study demonstrated elevated expression of both Sema3E in lung tissue and plasma samples from IPF patients, studies in systemic sclerosis have similarly shown increased Sema3E expression in the serum of patients with systemic sclerosis patients, corroborating our findings. The gene discussed is SEMA3E; the disease is systemic sclerosis.